Hyperion DeFi (NASDAQ:HYPD) Insider Hyunsu Jung Acquires 7,000 Shares of Stock

Hyperion DeFi, Inc. (NASDAQ:HYPD) insider Hyunsu Jung purchased 7,000 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The stock was acquired at an average cost of $3.70 per share, with a total value of $25,900.00. Following the transaction, the insider directly owned 1,384,676 shares of the company’s stock, valued at approximately $5,123,301.20. This represents a 0.51% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Hyunsu Jung also recently made the following trade(s):

• On Tuesday, June 2nd, Hyunsu Jung purchased 1,000 shares of Hyperion DeFi stock. The stock was acquired at an average cost of $3.66 per share, with a total value of $3,660.00.

Hyperion DeFi Stock Performance

NASDAQ:HYPD opened at $3.70 on Wednesday. Hyperion DeFi, Inc. has a 12-month low of $1.71 and a 12-month high of $17.18. The company has a quick ratio of 1.97, a current ratio of 1.97 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $56.09 million, a PE ratio of -0.37 and a beta of 2.47. The firm has a 50-day moving average price of $3.65 and a 200 day moving average price of $3.66.

Hyperion DeFi (NASDAQ:HYPD) last posted its quarterly earnings results on Thursday, March 26th. The company reported ($7.76) earnings per share (EPS) for the quarter. The company had revenue of $0.50 million for the quarter. Research analysts anticipate that Hyperion DeFi, Inc. will post 1.78 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

HYPD has been the topic of several recent analyst reports. Cantor Fitzgerald upgraded shares of Hyperion DeFi to a “strong-buy” rating in a research note on Thursday, April 9th. Zacks Research downgraded shares of Hyperion DeFi from a “hold” rating to a “strong sell” rating in a research note on Monday, March 30th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Hyperion DeFi in a research note on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $5.88.

Institutional Trading of Hyperion DeFi

Large investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC bought a new stake in Hyperion DeFi during the fourth quarter worth about $663,000. Jane Street Group LLC bought a new stake in Hyperion DeFi during the fourth quarter worth about $493,000. Focus Partners Advisor Solutions LLC bought a new stake in Hyperion DeFi during the fourth quarter worth about $221,000. Geode Capital Management LLC bought a new stake in Hyperion DeFi during the fourth quarter worth about $214,000. Finally, State Street Corp bought a new stake in Hyperion DeFi during the fourth quarter worth about $92,000. 25.84% of the stock is owned by institutional investors.

About Hyperion DeFi

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.